Cochlear logo

Cochlear(OTC) CHEOY

Market Cap$5.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)+101%
5 Year-40%
1 Year-50%
1 Month-7%
$44.60
-0.35%
-0.15Today
Cochlear last closing stock price
MetricPriceDate
Last closeUSD 44.752026-10-14
Cochlear stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.7%USD 45.072026-10-07
1 month-7.07%USD 48.152026-09-14
3 month+4.45%USD 42.842026-07-16
Year to date-47.08%USD 84.562025-12-31
1 year-49.71%USD 88.982025-10-14
3 year-41.73%USD 76.802023-10-13
5 year-39.61%USD 74.102021-10-15
Since inception+101.41%USD 22.222009-10-19

Cochlear Financials at a Glance

Market Cap

$5.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$4.69B

Net Income (TTM)

A$533.04M

EPS (TTM)

$0.73

P/E Ratio

61.08

Dividend

$1.23

Beta (Volatility)

0.70 (Low)

Price

$44.60

Volume

13,338

Open

$44.61

Previous Close

$44.75

Daily Range

$44.60 - $44.82

52-Week Range

$31.82 - $98.49

Estimated Earnings Date

Feb 11, 2026

CHEOY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cochlear

Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world.

Products and Services
  • Cochlear implant systems for hearing restoration
  • Enhanced sound processor upgrades for improved performance
  • Bone conduction technology and complementary accessories
Growth Outlook
  • Strong demand for hearing solutions drives market expansion
  • Investment in R&D supports innovative product development
  • Global aging population increases need for auditory devices
Financial Highlights
  • Recent quarterly revenue of 1.175 billion AUD reflects steady growth
  • Trailing twelve months (TTM) net income margin at 6.3% indicates profitability
  • Dividend yield of 2.42% offers attractive returns for investors
Founded in 1981 and headquartered in Sydney, Australia, Cochlear Limited has established itself as a leader in the medical devices industry. The company’s commitment to innovation and quality has resulted in a diverse product range that meets the needs of a growing global market. With a focus on research and development, Cochlear is well-positioned to capitalize on the increasing demand for hearing solutions, driven by an aging population and advancements in technology. Recent financial performance highlights the company's resilience and potential for future growth, making it an intriguing option for investors interested in the healthcare sector.
AI Generated • Sep 26, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

5,400

CEO

Diggory William Howitt, MBA

Website

www.cochlear.com

Headquarters

Sydney, NSW 2109, AU

CHEOY Financials

Key Financial Metrics (TTM)

Gross Margin

70.53%

Operating Margin

12.89%

Net Income Margin

6.31%

Return on Equity

8.01%

Return on Capital

10.71%

Return on Assets

5.66%

Earnings Yield

1.64%

Dividend Yield

2.74%

Payout Ratio

1.91%

Stock Overview

Market Cap

$5.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

130.80M

Volume

13.34K

Avg. Volume

24.25K

Financials (TTM)

Gross Profit

A$3.38B

Operating Income

A$823.88M

EBITDA

A$1.01B

Operating Cash Flow

A$615.69M

Capital Expenditure

-A$125.36M

Free Cash Flow

A$490.32M

Cash & ST Invst.

A$187.71M

Total Debt

A$212.71M

Cochlear Performance Analysis

Cochlear annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 1,315,608,22410.5%
20242024-06-30AUD 1,479,967,87812.5%
20252025-06-30AUD 1,525,689,0853.1%
20262026-06-30AUD 1,582,046,2783.7%
Cochlear sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-303.1%
Q42025-06-301.2%
Q22025-12-31-2.7%
Q42026-06-301.8%
Cochlear annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 1.53-3.7%
20242024-06-30AUD 1.7815.9%
20252025-06-30AUD 1.927.9%
20262026-06-30AUD 0.76-60.3%
Cochlear sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3023.8%
Q42025-06-30-10.3%
Q22025-12-31-13.2%
Q42026-06-30-109.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$1.18B

+3.3%

Gross Profit

A$801.05M

-6.9%

Gross Margin

68.17%

N/A

Market Cap

$5.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.08M

N/A

Employees

5,400

N/A

Net Income

-A$14.40M

-108.7%

EBITDA

A$136.50M

-53.4%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$187.71M

-63.5%

Total Debt

A$212.71M

-12.7%

Accounts Receivable

A$559.23M

+14.0%

Inventory

A$491.33M

+25.5%

Long Term Debt

A$170.71M

-15.5%

Short Term Debt

A$42.00M

+1.0%

Return on Assets

5.66%

N/A

Return on Invested Capital

15.06%

N/A

Free Cash Flow

A$208.32M

+8.6%

Operating Cash Flow

A$243.80M

+5.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNNDYGN Store Nord A/S
$48.04-0.33%
WILYYDemant A/S
$24.80+0.00%
COCHEnvoy Medical, Inc.
$0.62-2.71%
HRALHear AtLast Holdings, Inc.
$0.00+33.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
CCCCCC Intelligent Solutions
$7.62-0.24%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$103.05-6.78%
INTCIntel
$94.12-4.08%
CRWVCoreWeave
$66.94+1.76%

Questions About CHEOY

What is the current price of Cochlear?

Cochlear is trading at $44.60 per share.

What is the 52-week range for Cochlear?

Over the past 52 weeks, Cochlear has traded between $31.82 and $98.49.

How much debt does Cochlear have?

As of the most recent reporting period, Cochlear reported total debt of A$147.36M.

How much cash does Cochlear have on hand?

Cochlear reported A$130.04M in cash and cash equivalents in its most recent financial results.

What is Cochlear’s dividend yield?

Cochlear currently has a dividend yield of 2.74%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services